MacroGenics Inc (MGNX) USD0.01
2.77%- This stock can be held in a
Stocks and Shares ISASell:$5.10
Buy:$5.11
Change:
$0.29
(5.29%)
$0.29
(5.29%)Market closed | Prices delayed by at least 15 minutes
Sell:$5.10
Buy:$5.11
Change:$0.29
(5.29%)
$0.29
(5.29%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 4 April 2024 | Jeffrey Stuart PetersGeneral Counsel | Sell Option/Award related | 42,500 | $15.07 | $640,475.00 | 8,895 |
| 4 April 2024 | Jeffrey Stuart PetersGeneral Counsel | Sell Regular sell transaction (market) | 147 | $15.51 | $2,279.97 | 8,748 |
| 4 April 2024 | Jeffrey Stuart PetersGeneral Counsel | Sell Regular sell transaction (market) | 232 | $16.38 | $3,800.16 | 8,516 |
| 4 April 2024 | Jeffrey Stuart PetersGeneral Counsel | Sell Regular sell transaction (market) | 5,351 | $17.74 | $94,926.74 | 3,165 |
| 4 April 2024 | Jeffrey Stuart PetersGeneral Counsel | Sell Regular sell transaction (market) | 3,165 | $18.22 | $57,666.30 | 0 |
| 6 March 2024 | Jeffrey Stuart PetersGeneral Counsel | Sell Option/Award related | 19,625 | $21.50 | $421,937.50 | 8,895 |
| 4 March 2024 | James KarrelsCFO | Sell Regular sell transaction (market) | 30,000 | $20.50 | $615,000.00 | 171,452 |
| 4 March 2024 | Eric Blasius RisserCOO | Sell Option/Award related | 15,000 | $20.00 | $300,000.00 | 65,059 |
| 4 March 2024 | Eric Blasius RisserCOO | Sell Regular sell transaction (market) | 26,159 | $19.63 | $513,501.17 | 38,900 |
| 4 March 2024 | Thomas M. (Tom) SpitznagelSenior Vice President | Sell Option/Award related | 10,000 | $20.00 | $200,000.00 | 8,316 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 7 September 2023 | BIOTECH TARGET NVInvestment Company | Buy Regular purchase transaction | 200,000 | $5.26 | $1,052,840.00 | 9,779,963 |
| 5 February 2024 | Jeffrey Stuart PetersGeneral Counsel | Sell Option/Award related | 54,376 | $16.50 | $897,204.00 | 21,875 |
| 2 October 2023 | BIOTECH TARGET NVInvestment Company | Buy Regular purchase transaction | 150,000 | $4.46 | $669,585.00 | 9,929,963 |
| 4 April 2024 | Jeffrey Stuart PetersGeneral Counsel | Sell Option/Award related | 42,500 | $15.07 | $640,475.00 | 8,895 |
| 4 March 2024 | James KarrelsCFO | Sell Regular sell transaction (market) | 30,000 | $20.50 | $615,000.00 | 171,452 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.